Atrium Health execs talk Covid vaccination progress as they prep for upcoming year

Nearly all of Atrium Health's employees — 99.5% — are in compliance with the system's Covid-19 vaccination mandate, CEO Gene Woods said.
Source: Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news

Related Links:

An Israeli hospital says preliminary research indicates a fourth dose of the coronavirus vaccine provides only limited defense against the omicron variant that's raging around the world
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
The increase in antibodies produced by a fourth shot of COVID-19 vaccine is not enough to prevent infections from omicron, study shows. Latest news.
Source: Reuters: Health - Category: Consumer Health News Source Type: news
A safety panel of the European drug regulator on Friday recommended adding a rare spinal inflammation called transverse myelitis as a side effect of AstraZeneca's COVID-19 vaccine.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
A growing number of countries are rolling out extra booster shots despite a lack of evidence about their effectiveness.
Source: Healthcare News - Category: Pharmaceuticals Authors: Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
Researchers at the University of Pennsylvania School of Medicine have created a new coating for nanoparticles that can help to protect them from attacks by the immune system. The approach, which uses naturally occurring proteins that can inhibit the ...
Source: Medgadget - Category: Medical Devices Authors: Tags: Medicine Nanomedicine @PennHealthTech @PennMedicine @SUBiodesign upenn Source Type: blogs
Combined vaccine should be ready in time for winter infectious season in 2023, says drug firm ’s chief executiveModerna is aiming to launch a single booster vaccination that will protect against both Covid-19 and flu within two years, its chief executive has said.St éphane Bancel said that the combined vaccine – which will protect against Covid-19, influenza and RSV, a common respiratory virus – could be available before the winter infectious season in 2023.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Pharmaceuticals industry Coronavirus Medical research Business Flu World news Science Source Type: news
Information for healthcare professionals on myocarditis and pericarditis following COVID-19 vaccination. 17 January 2022Updated the'Why are serum samples being requested if myocarditis is suspected after receiving a COVID-19 vaccine?'section. 21 December 2021Updated information with latest data.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
Italy has made vaccination compulsory for over 50s and Austria will require vaccination against Covid-19 for all adults starting from February.
Source: Healthcare News - Category: Pharmaceuticals Authors: Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
MONDAY, Jan. 17, 2022 -- The latest shipment of 1.1 million COVID-19 vaccines to Rwanda this weekend signaled a noteworthy achievement: The COVAX program, a United Nations-backed program providing poorer countries with vaccines, has now shipped one...
Source: - Daily MedNews - Category: General Medicine Source Type: news
[Ghanaian Times] The Ghana Health Service (GHS) is to begin administering booster doses of the COVID-19 vaccines in the coming days to improve immunity of persons who are fully vaccinated across the country.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
More News: COVID-19 | Genetics | Health Management | Pharmaceuticals | Vaccines